Huiping Zhang, PhD

Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Huiping Zhang, PhD is a Professor in the Department of Psychiatry and the Department of Medicine (Section of Biomedical Genetics) at the Boston University Chobanian & Avedisian School of Medicine. He previously held academic appointments at Yale University School of Medicine, where he completed his postdoctoral training and advanced through roles as Research Associate Scientist (equivalent to Research Assistant Professor), Assistant Professor (tenure-track), and Research Scientist (equivalent to Research Associate Professor) before joining Boston University as an Associate Professor in 2017. Dr. Zhang’s research investigates the genetic and epigenetic mechanisms underlying substance use disorders (SUDs) and related psychiatric conditions. His work has been supported by multiple NIH awards, including a K99/R00, an R21, and two R01 grants from the National Institute on Drug Abuse (NIDA) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA). He has also served as a subcontract Principal Investigator on two R01 projects funded by the National Institute of Child Health and Human Development (NICHD). In addition to his research, Dr. Zhang is actively engaged in academic publishing. He serves on the editorial boards of several peer-reviewed journals, including PLOS ONE, Frontiers in Genetics, Frontiers in Psychiatry, Frontiers in Cell and Developmental Biology, and Complex Psychiatry.

Publications

  • Published 5/19/2026

    Sofiya Patra, Ji Sun Koo, Abhyuday Singh Parihar, Chao Zhang, Huiping Zhang. Single-nucleus RNA sequencing identifies transcriptomic signatures of alcohol use disorder in the human ventral tegmental area. medRxiv. 2026.

    Read at: Custom

  • Published 3/26/2026

    Koo JS, Zhan Q, Zhang H. m6A RNA methylation regulatory gene expression in response to ethanol and acetaldehyde exposure and withdrawal. Environ Epigenet. 2026; 12(1):dvag011. PMID: 41970606.

    Read at: PubMed

  • Published 1/22/2026

    Wang LC, Lu AK, Zhu ZH, Hou WL, Yin X, Yang Q, Man LJ, Chen J, Zhu HL, Yu X, Zhang H, Hui L. Association between reduced plasma dopamine ß-hydroxylase levels and immediate memory impairment in first-episode drug-naïve schizophrenia. Schizophr Res. 2026 Mar; 289:94-99. PMID: 41576833.

    Read at: PubMed

  • Published 1/8/2026

    Zhu ZH, Wu YM, Wang JJ, Zhang LW, Yin XY, Jia NN, Zhu HH, Cai Y, Hou WL, Yu X, Zhang H, Hui L. Prevalence and cognitive correlates of sleep problems in Chinese patients with first-episode drug-naïve schizophrenia. BMC Psychiatry. 2026 Jan 08; 26(1):127. PMID: 41507882.

    Read at: PubMed

  • Published 12/15/2025

    Ye G, Hou WL, Li J, Man LJ, Zhu ZH, Yin XY, Yu X, Zhang H, Hui L. Association between increased serum TNF-a levels and immediate memory impairment in patients with major depressive disorder: pilot study. BJPsych Open. 2025 Dec 15; 12(1):e16. PMID: 41392773.

    Read at: PubMed

View All 97 Publications:   View Full Profile in BUMC

Other Positions

  • Professor, Medicine
    Boston University Chobanian & Avedisian School of Medicine
  • Member, Genome Science Institute
    Boston University
  • Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
    Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences

Websites

Education

  • Queen's University, PhD
  • Tongji Medical University, MS
  • Central China Normal University, BS

View all profiles